Sulfamethoxazole (SMX) is an old sulfonamide antibiotic that was launched first in
combination with trimethoprim in 1969 by F. Hoffmann‐La Roche. Although sales figures for …

In this study, exposure and ecotoxicity data of six human pharmaceuticals (carbamazepine,
clofibric acid, diclofenac, ofloxacin, propranolol, and sulfamethoxazole) were collected …

An environmental risk assessment (ERA) for the aquatic compartment in Europe from human
use was developed for the old antibiotic Trimethoprim (TMP), comparing exposure and …

In this study, eleven commonly used antibiotics including sulfonamides, tetracyclines,
aminoglycosides, fluoroquinolones, and beta-lactams were evaluated for their acute and …

The growing concern over the release of pharmaceutically active compounds and personal
care products into the environment has prompted the introduction of risk assessment …

An environmental risk assessment of eleven pharmaceuticals according to the guideline
recommended by the European Medicines Evaluation Agency (EMEA) was performed …

The aquatic toxicity of sulfaquinoxaline (SQO) and sulfaguanidine (SGD) was evaluated on
the following test organisms: Daphnia magna (reproduction test), Pseudokirchneriella …

Antibiotics have a wide application range in human and veterinary medicines. Being
designed for pharmacological stability, most antibiotics are recalcitrant to biodegradation …

In recent years, concern regarding the environmental presence of sulfonamides (SAs) and
other species of antibiotics has increased considerably due mainly to the potential spread of …

Sulfamethoxazole (SMX) is a sulfonamide antibiotic, widely used as curative and preventive
drug for human, animal, and aquaculture bacterial infections. Its residues have been …